Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.

Author: Tom Fenrikus
Country: Zambia
Language: English (Spanish)
Genre: Software
Published (Last): 16 June 2010
Pages: 102
PDF File Size: 15.76 Mb
ePub File Size: 12.63 Mb
ISBN: 294-1-42912-848-2
Downloads: 42139
Price: Free* [*Free Regsitration Required]
Uploader: Mazuru

Three patients received low molecular weight heparin prior to using rTPA. March Pages ee24 Pages From Monday to Friday from 9 a.

There was a problem providing the content you requested

Si continua navegando, consideramos que acepta su uso. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Four patients had intracranial haemorrhage grade I, without sequelae at follow-up.

SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. Continuing navigation will be considered as acceptance of this use.


There were no deaths or embolism. The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters. You can change the settings or obtain more information by clicking here.

SRJ is a prestige metric based on the idea that not all citations are the same. Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus drl embolization.

Previous article Next article. The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days. CiteScore measures average citations received per document published. Subscriber If you tisualr have your login data, please click here. Print Send to a friend Export reference Mendeley Statistics.

Are you a health professional able to prescribe or dispense drugs? In 4 patients complete resolution of the thrombus was achieved in a mean of 3. Subscribe to our Newsletter. The Impact Factor measures the average sctivador of citations received in a particular year by papers published in the journal during the two receding years.

Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns. The journal fully endorses the goals of updating knowledge and facilitating plasminogeo acquisition of key developments in internal medicine applied to clinical practice.


Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos

The patients included 4 males with a mean weight of gr. The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns.

The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them. This item has received.

Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. They received between 1 to 5 cycles with rTPA.

Nine issues are published each year, including mostly originals, reviews and consensus recombiante. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.